Exosomes tailored
to your specific
drug delivery needs
learn
more
Safe and effective drug delivery solutions
About us
Focused on extracellular vesicles, we pioneer
breakthroughs in targeted drug delivery. We equip
exosomes with tissue-specific GPS systems, optimising cargo delivery and enhancing its clinical performance.

Our technology enables us to reach many previously unaddressed therapeutic targets, supporting the
development of innovative biological therapeutics.
By redefining how therapeutics reach their intended targets, we aim to improve the efficacy and safety of treatments.
Our vision?
A future of healthcare with
safe, precise, effective and
personalised therapies.
Inspired by the potential of extracellular vesicles, through
commitment to innovation, ethical practices, and global
collaboration will we aim to set new standards in tissue-
specific drug delivery. We develop a platform offering a
diverse portfolio of tissue specific drug delivery vehicles,
supporting progress of advanced therapies to shape healthier
future and improve lives on a global scale.
Team
Our journey is fuelled by the vision and passion of Kasia and Kamila. Together, guided by shared fascination with exosomes, they are dedicated to rewriting the rules of modern medicine and
being at the forefront of medical revolution.
At Excellio, we believe in the power of exosomes to inspire hope, drive change, and improve lives worldwide. Join us as we embark on this extraordinary journey towards a future where targeted, personalised therapies are the cornerstone of healthcare. Inspired by the transformative potential of exosomes, we stand at the forefront of innovation in drug delivery.
Kasia Maj
Co-founder & CEO
Kamila Małysz
Co-founder & CSO
Technology
Overview - why exosomes?
Exosomes are extracellular vesicles secreted by every
cell in the body, crucial player in the process of
intercellular communication. They significantly
contribute to vital cellular functions such as immune
responses, maintaining tissue balance, and promoting
regeneration. However, these pathways can also
contribute to the development of various diseases,
including cancer, neurodegenerative conditions, and
cardiovascular issues. As a result, exosomes have the
potential to be engineered as ideal therapeutic tools
for addressing these diseases.
Overview - why exosomes?
Exosomes are extracellular vesicles secreted by every cell in the body, crucial player in the process of intercellular communication. They significantly contribute to vital cellular functions such as immune responses, maintaining tissue balance, and promoting regeneration. However, these pathways can also contribute to the development of various diseases, including cancer, neurodegenerative conditions, and cardiovascular issues. As a result, exosomes have the potential to be engineered as ideal therapeutic tools for addressing these diseases.
Exosomes
for drug delivery
Exosomes stand out as exceptionally potent vehicles
for drug delivery due to their distinct characteristics.
Their lipid makeup is enriched with non-lamellar
forming lipids, fostering beneficial shapes in their
lipid bilayer, a trait that enhances drug delivery effectiveness. The asymmetry of the exosome lipid
bilayer also plays a crucial role, offering advantages
for interactions with the plasma membrane and,
notably, with target cells. The abundance of both
integral and peripheral membrane proteins in
exosomes facilitates the effective transfer of
therapeutic agents through cell-to-cell
communication. These proteins can be engineered
in their progenitor cells to display specific targeting groups on their surface, allowing for precise
alterations in exosomes for targeted drug
conveyance. Additionally, the versatility of exosomes
as drug carriers is underscored by their capacity to
transport a wide array of therapeutic payloads, such
as small molecule drugs, nucleic acids, proteins,
peptides, and different nanomaterials, to achieve
the intended biological effect.
Exosomes stand out as exceptionally potent vehicles for drug delivery due to their distinct characteristics. Their lipid makeup is enriched with non-lamellar forming lipids, fostering beneficial shapes in their lipid bilayer, a trait that enhances drug delivery effectiveness. The asymmetry of the exosome lipid bilayer also plays a crucial role, offering advantages for interactions with the plasma membrane and, notably, with target cells. The abundance of both integral and peripheral membrane proteins in exosomes facilitates the effective transfer of therapeutic agents through cell-to-cell communication. These proteins can be engineered in their progenitor cells to display specific targeting groups on their surface, allowing for precise alterations in exosomes for targeted drug conveyance. Additionally, the versatility of exosomes as drug carriers is underscored by their capacity to transport a wide array of therapeutic payloads, such as small molecule drugs, nucleic acids, proteins, peptides, and different nanomaterials, to achieve the intended biological effect.
Ultimate
nanocarriers
The natural attributes of exosomes sourced from
various cells grant them an intrinsic selectivity,
allowing for the preferential absorption of exosomes
by specific tissue types corresponding to their cell of
origin. This unique trait can be leveraged to craft
specialised vectors for cutting-edge therapeutic
applications. Additionally, these exosomes can
undergo further modifications to boost their target
specific delivery capabilities. At Excellio, we harness
the innate capabilities of exosomes, augmenting
them with pioneering engineering techniques to forge the optimal vehicles for drug delivery. (include nucleic acid delivery).
The natural attributes of exosomes sourced from various cells grant them an intrinsic selectivity, allowing for the preferential absorption of exosomes by specific tissue types corresponding to their cell of origin. This unique trait can be leveraged to craft specialised vectors for cutting-edge therapeutic applications. Additionally, these exosomes can undergo further modifications to boost their target specific delivery capabilities. At Excellio, we harness the innate capabilities of exosomes, augmenting them with pioneering engineering techniques to forge the optimal vehicles for drug delivery. (include nucleic acid delivery).
Tissue-specific
exosomes
Exosomes released by various tissues and cells
possess distinct characteristics. For instance,
exosomes originating from tumors influence several
tumor behaviors, including growth, angiogenesis,
invasion, and metastasis. On the other hand,
exosomes derived from mesenchymal stem cells
(MSCs) are noted for their beneficial properties,
making them suitable as adjuncts to enhance and
support other therapeutic strategies. Delving into
the unique features of exosomes from different
cellular origins can unlock their full therapeutic
potential. Moreover, a comprehensive exploration of
these diverse cell-sourced exosomes can provide
new perspectives on the pathological processes
underlying various diseases.
Exosomes released by various tissues and cells
possess distinct characteristics. For instance,
exosomes originating from tumors influence several tumor behaviors, including growth, angiogenesis, invasion, and metastasis. On the other hand, exosomes derived from mesenchymal stem cells (MSCs) are noted for their beneficial properties, making them suitable as adjuncts to enhance and support other therapeutic strategies. Delving into the unique features of exosomes from different cellular origins can unlock their full therapeutic potential. Moreover, a comprehensive exploration of these diverse cell-sourced exosomes can provide new perspectives on the pathological processes underlying various diseases.
Platform
Tissue specific delivery of therapeutics
Cancer
In the progression of cancer, exosomes can
function as biological reprogramming elements for tumour cells. Studies suggest that exosomes can regulate tumour growth by transferring specific proteins and RNAs to cancerous cells. The miRNAs within exosomes have demonstrated capabilities to suppress the proliferation, migration, and invasion of cancer cells. These mechanisms have been investigated across a range of cancer types, such as bladder, colorectal, and breast cancers, showcasing their potential in modulating tumour behaviour.
Neurodegenerative disease
Exosomes hold significant therapeutic promise for neurological conditions, thanks to their capability to penetrate the blood-brain barrier (BBB). Research indicates that exosomal miRNAs from mesenchymal stem cells (MSCs) can positively influence the pathology of several brain disorders. For example, specific miRNAs like miR-21, miR-29b, and miR-146a have been linked to improvements in Alzheimer's disease. Similarly, conditions such as subarachnoid haemorrhage and traumatic brain injury have seen potential benefits from miRNAs like miR-21, miR-193b, and miR-216a, showcasing the broad potential of exosomes in neurotherapeutic applications.
Cardiovascular disease
Emerging research has shown that stem cell derived exosomes can promote angiogenesis, offer cellular protection, and influence apoptosis. Furthermore, a distinct investigation revealed that exosomes from cardiac-derived progenitor cells (CDCs), enriched with specific miRNAs, can enhance cardioprotective responses. In experiments involving animal models of ischemia reperfusion injury, the administration of these exosomes to macrophages post-reperfusion correlated with a decrease in the size of the heart infarct, highlighting their therapeutic promise in cardiovascular disease management.
Regenerative medicine
By harnessing the power of exosomes, researchers develop innovative therapies that can restore function and structure to damaged tissues. In particular, exosomes derived from stem cells have shown potential in promoting regeneration. They facilitate communication between cells, encouraging tissue repair and reducing inflammation. For instance, in studies focused on skin regeneration, exosomes have been found to accelerate wound healing, suggesting their role in enhancing tissue repair mechanisms.





Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact us
Excellio Labs
Roslin Innovation Centre
Easter Bush Campus
EH25 9RG
Edinburgh
Exosomes tailored to your specific drug delivery needs
Safe and effective drug delivery solutions
About us
Focused on extracellular vesicles, we pioneer breakthroughs in targeted drug delivery. We equip exosomes with tissue-specific GPS systems, optimising cargo delivery and enhancing its clinical performance.
Our technology enables us to reach many previously unaddressed therapeutic targets, supporting the development of innovative biological therapeutics. By redefining how therapeutics reach their intended targets, we aim to improve the efficacy and safety of treatments.
Our vision?
A future of healthcare with safe, precise, effective and  personalised therapies.
Inspired by the potential of extracellular vesicles, through commitment to innovation, ethical practices, and global collaboration will we aim to set new standards in tissue-specific drug delivery. We develop a platform offering a diverse portfolio of tissue specific drug delivery vehicles, supporting progress of advanced therapies to shape healthier future and improve lives on a global scale.
Team
Our journey is fuelled by the vision and passion of Kasia and Kamila. Together, guided by shared fascination with exosomes, they are dedicated to rewriting the rules of modern medicine and being at the forefront of medical revolution.
At Excellio, we believe in the power of exosomes to inspire hope, drive change, and improve lives worldwide. Join us as we embark on this extraordinary journey towards a future where targeted, personalised therapies are the cornerstone of healthcare. Inspired by the transformative potential of exosomes, we stand at the forefront of innovation in drug delivery.
Kasia Maj
Co-founder & CEO
Kamila Małysz
Co-founder & CSO
Technology
Overview - why exosomes?
Exosomes are extracellular vesicles secreted by every cell in the body, crucial player in the process of intercellular communication. They significantly contribute to vital cellular functions such as immune responses, maintaining tissue balance, and promoting regeneration. However, these pathways can also contribute to the development of various diseases, including cancer, neurodegenerative conditions, and cardiovascular issues. As a result, exosomes have the potential to be engineered as ideal therapeutic tools for addressing these diseases.
Exosomes
for drug delivery
Exosomes stand out as exceptionally potent vehicles for drug delivery due to their distinct characteristics. Their lipid makeup is enriched with non-lamellar forming lipids, fostering beneficial shapes in their lipid bilayer, a trait that enhances drug delivery effectiveness. The asymmetry of the exosome lipid bilayer also plays a crucial role, offering advantages for interactions with the plasma membrane and, notably, with target cells. The abundance of both integral and peripheral membrane proteins in exosomes facilitates the effective transfer of therapeutic agents through cell-to-cell communication. These proteins can be engineered in their progenitor cells to display specific targeting groups on their surface, allowing for precise alterations in exosomes for targeted drug conveyance. Additionally, the versatility of exosomes as drug carriers is underscored by their capacity to transport a wide array of therapeutic payloads, such as small molecule drugs, nucleic acids, proteins, peptides, and different nanomaterials, to achieve the intended biological effect.
Tissue-specific
exosomes
Exosomes released by various tissues and cells possess distinct characteristics. For instance, exosomes originating from tumors influence several tumor behaviors, including growth, angiogenesis, invasion, and metastasis. On the other hand, exosomes derived from mesenchymal stem cells (MSCs) are noted for their beneficial properties, making them suitable as adjuncts to enhance and support other therapeutic strategies. Delving into the unique features of exosomes from different cellular origins can unlock their full therapeutic potential. Moreover, a comprehensive exploration of these diverse cell-sourced exosomes can provide new perspectives on the pathological processes underlying various diseases.
Ultimate
nanocarriers
The natural attributes of exosomes sourced from various cells grant them an intrinsic selectivity, allowing for the preferential absorption of exosomes by specific tissue types corresponding to their cell of origin. This unique trait can be leveraged to craft specialized vectors for cutting-edge therapeutic applications. Additionally, these exosomes can undergo further modifications to boost their target-specific delivery capabilities. At Excellio, we harness the innate capabilities of exosomes, augmenting them with pioneering engineering techniques to forge the optimal vehicles for drug delivery. (include nucleic acid delivery).
Platform
Tissue specific delivery
of therapeutics
Cancer
In the progression of cancer, exosomes can function as biological reprogramming elements for tumour cells. Studies suggest that exosomes can regulate tumour growth by transferring specific proteins and RNAs to cancerous cells. The miRNAs within exosomes have demonstrated capabilities to suppress the proliferation, migration, and invasion of cancer cells. These mechanisms have been investigated across a range of cancer types, such as bladder, colorectal, and breast cancers, showcasing their potential in modulating tumour behaviour.
Neurodegenerative disease
Exosomes hold significant therapeutic promise for neurological conditions, thanks to their capability to penetrate the blood-brain barrier (BBB). Research indicates that exosomal miRNAs from mesenchymal stem cells (MSCs) can positively influence the pathology of several brain disorders. For example, specific miRNAs like miR-21, miR-29b, and miR-146a have been linked to improvements in Alzheimer's disease. Similarly, conditions such as subarachnoid haemorrhage and traumatic brain injury have seen potential benefits from miRNAs like miR-21, miR-193b, and miR-216a, showcasing the broad potential of exosomes in neurotherapeutic applications.
Cardiovascular disease
Emerging research has shown that stem cell-derived exosomes can promote angiogenesis, offer cellular protection, and influence apoptosis. Furthermore, a distinct investigation revealed that exosomes from cardiac-derived progenitor cells (CDCs), enriched with specific miRNAs, can enhance cardioprotective responses. In experiments involving animal models of ischemia-reperfusion injury, the administration of these exosomes to macrophages post-reperfusion correlated with a decrease in the size of the heart infarct, highlighting their therapeutic promise in cardiovascular disease management.
Regenerative medicine
By harnessing the power of exosomes, researchers develop innovative therapies that can restore function and structure to damaged tissues. In particular, exosomes derived from stem cells have shown potential in promoting regeneration. They facilitate communication between cells, encouraging tissue repair and reducing inflammation. For instance, in studies focused on skin regeneration, exosomes have been found to accelerate wound healing, suggesting their role in enhancing tissue repair mechanisms.
Contact us
Excellio Labs
Roslin Innovation Centre
Easter Bush Campus
EH25 9RG
Edinburgh
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.